Background: Vitamin D deficiency is common in CF. Whether vitamin D affects pulmonary function in CF is unknown. Methods: Data were abstracted from clinically stable CF patients who had pulmonary function studies and serum 25-hydroxyvitamin D [25(OH)D, ng/ml] levels drawn within 2. months of each other. Findings were adjusted for multiple variables known to affect pulmonary function in CF. Results: Enrollees totaled 597. Overall mean 25(OH)D level was 29.6±12.8ng/ml (SD). Serum 25(OH)D levels showed a significant correlation with forced expiratory volume in 1s (FEV1) % predicted (r=0.20, p<0.0001) and forced vital capacity % predicted (r=0.13, p=0.0019). Multivariate analysis revealed that serum 25(OH)D remained an independent predictor of FEV1 % predicted even after controlling for multiple other factors known to affect CF lung function. Conclusions: Serum 25(OH)D levels are significantly associated with pulmonary function in CF. Further study is required to determine whether this association is causal.
|Original language||English (US)|
|Number of pages||10|
|Journal||Journal of Cystic Fibrosis|
|State||Published - Jul 1 2015|
All Science Journal Classification (ASJC) codes
- Pediatrics, Perinatology, and Child Health
- Pulmonary and Respiratory Medicine